Skip to content

transvaginal natural orifice transluminal endoscopic pelvic reconstruction with Y shape mesh versus transvaginal natural orifice transluminal endoscopic sacro-uerospianl ligament suspension in pelvic organ prolapse:a prospectiv randomized controlled trails

transvaginal natural orifice transluminal endoscopic pelvic reconstruction with Y shape mesh versus transvaginal natural orifice transluminal endoscopic sacro-uerospianl ligament suspension in pelvic organ prolapse:a prospectiv randomized controlled trails

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062319
Enrollment
Unknown
Registered
2022-08-01
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

A:transvaginal natural orifice transluminal endoscopic pelvic reconstruction with Y shape mesh
B:transvaginal natural orifice transluminal endoscopic sacro-uerospianl ligament suspension

Sponsors

Affiliated obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with pelvic organ prolapse diagnosed and treated in the affiliated obstetrics and Gynecology Hospital of Fudan University from July 2021 to November 2022; 2. Patients who have informed consent and signed the informed consent form; 3. Adult women aged 50-80; 1) Patients with grade III or above in at least one part and grade II or above in other parts; 2) Patients who refused conservative treatment and failed conservative treatment; 3) Patients with sexual needs; 4. Patients who were followed up for 2-3 years after operation.

Exclusion criteria

Exclusion criteria: 1) Patients with a history of pelvic radiotherapy; 2) Patients with a history of prolapse treated with transvaginal mesh; 3) Women with reproductive requirements; Pregnant or lactating patients; 4) Patients with immune diseases and long-term use of steroids; 5) Patients currently smoking; 6) Patients with pelvic pain syndrome (such as fibromyalgia, bladder pain syndrome) that may lead to increased sensitivity to pelvic pain; 7) Patients suspected of pelvic malignancy; 8) Patients with pain caused by lumbar and sacral organic diseases (such as lumbar disc herniation and mandatory spondylitis) 9) Patients who are too old to tolerate surgery or whose surgical benefits are significantly less than surgical trauma.

Design outcomes

Secondary

MeasureTime frame
Intraoperative conditions: operation time, amount of bleeding, length of hospital stay, hospitalization expenses, pain score, whether there are intraoperative complications and their specific conditions.;Short term postoperative conditions: failure rate, vaginal length, vaginal width, urinary incontinence, urinary retention, improvement of quality of life, socio-economic evaluation.;

Countries

China

Contacts

Public ContactChen Yisong
cys373900207@aliyun.com+86 13601913713

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026